My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 271

    1.

    Viewpoint: limiting prostate cancer screening.

    Hoffman RM.

    Ann Intern Med. 2006 Mar 21;144(6):438-40.PMID: 16549856 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Viewpoint: expanding prostate cancer screening.

    Catalona WJ, Loeb S, Han M.

    Ann Intern Med. 2006 Mar 21;144(6):441-3.PMID: 16549857 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Screening for prostate cancer--how to manage in 2006?

    Lobel B.

    Acta Chir Iugosl. 2005;52(4):19-21.PMID: 16673588 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?

    Amling CL.

    Curr Treat Options Oncol. 2006 Sep;7(5):337-45. Review.PMID: 16904050 [PubMed - indexed for MEDLINE]Related articles

    5.

    Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy.

    Spurgeon SE, Mongoue-Tchokote S, Collins L, Priest R, Hsieh YC, Peters LM, Beer TM, Mori M, Garzotto M.

    Urology. 2007 May;69(5):931-5.PMID: 17482937 [PubMed - indexed for MEDLINE]Related articles

    6.

    Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.

    Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.

    Urology. 2008 May;71(5):787-91. Epub 2008 Feb 11.PMID: 18267334 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.

    Beaulac JA, Fry RN, Onysko J.

    Can J Public Health. 2006 May-Jun;97(3):171-6.PMID: 16827400 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Prostate cancer and prostate specific antigen screening]

    Camici M.

    Minerva Med. 2004 Feb;95(1):25-34. Review. Italian. PMID: 15041924 [PubMed - indexed for MEDLINE]Related articles

    9.

    Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

    Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

    Am J Med. 1998 Jun;104(6):526-32.PMID: 9674714 [PubMed - indexed for MEDLINE]Related articles

    10.

    How to use PSA to screen for prostate cancer.

    Little B, Young M.

    Int J Clin Pract. 2003 Jan-Feb;57(1):40-2. Review.PMID: 12587941 [PubMed - indexed for MEDLINE]Related articles

    11.

    Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.

    Lim LS, Sherin K; ACPM Prevention Practice Committee.

    Am J Prev Med. 2008 Feb;34(2):164-70. Review. Erratum in: Am J Prev Med. 2008 May;34(5):454. PMID: 18201648 [PubMed - indexed for MEDLINE]Related articles

    12.

    Digital rectal examination as a prostate cancer-screening method in a country with a low incidence of prostate cancer.

    Shim HB, Lee SE, Park HK, Ku JH.

    Prostate Cancer Prostatic Dis. 2007;10(3):250-5. Epub 2007 Feb 13.PMID: 17297501 [PubMed - indexed for MEDLINE]Related articles

    13.

    Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

    Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.PMID: 18678846 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.

    Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR.

    Int J Urol. 2007 May;14(5):406-11.PMID: 17511722 [PubMed - indexed for MEDLINE]Related articles

    15.

    Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review.

    Pepe P, Panella P, D'Arrigo L, Savoca F, Pennisi M, Aragona F.

    Oncology. 2006;70(2):81-9. Epub 2006 Apr 4. Review.PMID: 16601365 [PubMed - indexed for MEDLINE]Related articles

    16.

    Practitioner-level determinants of inappropriate prostate-specific antigen screening.

    Kerfoot BP, Holmberg EF, Lawler EV, Krupat E, Conlin PR.

    Arch Intern Med. 2007 Jul 9;167(13):1367-72.PMID: 17620529 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening.

    Porter MP, Stanford JL, Lange PH.

    Prostate. 2006 Jul 1;66(10):1044-51.PMID: 16598738 [PubMed - indexed for MEDLINE]Related articles

    18.

    Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

    Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK.

    BJU Int. 2007 Apr;99(4):775-9. Epub 2007 Jan 12.PMID: 17223921 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.

    Ito K.

    Int J Urol. 2009 May;16(5):458-64. Epub 2009 Apr 1. Review.PMID: 19341365 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).

    Srinualnad S, Charoenkraikamol C, Toraksa S, Uiprasertkul M, Amornvesukit T, Taweemonkongsap T, Udompunturak S, Nualyong C, Tantiwong A.

    J Med Assoc Thai. 2006 Jan;89(1):37-42.PMID: 16583579 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity